natgillin/translations-raw huggingface dataset:
2 Mean data shown for convenience, categorical analysis performed using van Elteren test ITT: Intent-To-Treat; RDO: Retrieved Drop Outs; LOCF: Last Observation Carried Forward 
ITT: Intent-To-Treat (namera zdravljenja); RDO: Retrieved Drop Outs (nadomeščeni izpadli); LOCF: Last Observation Carried Forward (zadnje opažanje preneseno naprej).
In patients with Alzheimer's disease, inhibition of AChE in CSF by rivastigmine was dose-dependent up to 6 mg given twice daily, the highest dose tested. 
Pri bolnikih z Alzheimerjevo boleznijo je bilo zaviranje AChE v cerebrospinalni tekočini odvisno od odmerka do 6 mg rivastigmina dvakrat na dan, kar je bil največji preskušeni odmerek.
Rivastigmine Teva might interfere with anticholinergic medicines (medicines used to relieve stomach cramps or spasms, to treat Parkinson's disease or to prevent travel sickness). 
(zdravil, ki se uporabljajo za lajšanje želodčnih krčev ali spazmov, za zdravljenje Parkinsonove bolezni ali za preprečevanje potovalne bolezni).
Subjects with hepatic impairment: 
Bolniki z ledvično okvaro:
Very common (affects more than 1 patient in 10) Common (affects 1 to 10 patients in 100) Uncommon (affects 1 to 10 patients in 1,000) Rare (affects 1 to 10 patients in 10, 000) Very rare (affects less than 1 patient in 10,000) Not known (frequency cannot be estimated from the available data) 
Pogostnosti so opredeljene, kot sledi: zelo pogosti (pojavijo se pri več kot 1 bolniku od 10 bolnikov) pogosti (pojavijo se pri 1 do 10 bolnikih od 100 bolnikov) občasni (pojavijo se pri 1 do 10 bolnikih od 1.000 bolnikov) redki (pojavijo se pri 1 do 10 bolnikih od 10.000 bolnikov) zelo redki (pojavijo se pri manj kot 1 bolniku od 10.000 bolnikov) neznana (pogostnosti iz razpoložljivih podatkov ni mogoče oceniti)
Care should be exercised in treating patients with active gastric or duodenal ulcers or patients predisposed to these conditions. 
Pri zdravljenju bolnikov z aktivnimi razjedami želodca ali dvanajstnika, ali bolnikov, ki so tem boleznim nagnjeni, je potrebna previdnost.
Rivastigmine Teva 1.5 mg hard capsules Rivastigmine Teva 3 mg hard capsules Rivastigmine Teva 4.5 mg hard capsules Rivastigmine Teva 6 mg hard capsules Rivastigmine 
Rivastigmine Teva 1,5 mg trde kapsule Rivastigmine Teva 3 mg trde kapsule Rivastigmine Teva 4,5 mg trde kapsule Rivastigmine Teva 6 mg trde kapsule rivastigmin
This medicinal product does not require any special storage conditions Medicines should not be disposed of via wastewater or household waste. 
Zdravil ne smete odstraniti v odpadne vode ali gospodinjske odpadke.
The results for clinically relevant responders pooled from two flexible dose studies out of the three pivotal 26-week multicentre studies in patients with mild-to-moderately severe Alzheimer's Dementia, are provided in Table 4 below. 
V tabeli 4 spodaj so navedeni rezultati za bolnike, ki so se klinično pomembno odzivali na zdravljenje, zbrane iz dveh študij s prožnimi odmerki med tremi ključnimi 26-tedenskimi multicentričnimi študijami pri bolnikih z blago do zmerno Alzheimerjevo demenco.
Cmax and AUC of rivastigmine were more than twice as high in subjects with moderate renal impairment compared with healthy subjects; however there were no changes in Cmax and AUC of rivastigmine in subjects with severe renal impairment. 
Pri bolnikih z zmerno ledvično okvaro sta bili vrednosti Cmax in AUC rivastigmina več kot dvakrat večji, kot pri zdravih osebah; vendar pri osebah s hudo ledvično okvaro sprememb vrednosti Cmax in AUC rivastigmina niso opazili.
The efficacy of rivastigmine has been established through the use of three independent, domain specific, assessment tools which were assessed at periodic intervals during 6 month treatment periods. 
Učinkovitost rivastigmina so ugotovili s tremi neodvisnimi orodji za ocenjevanje, specifičnimi za to področje.
- 50 x 1 capsules in PVC/Alu push through perforated unit dose blisters Not all pack sizes may be marketed. 
- 50 x 1 kapsula v pretisnem omotu iz PVC/Alu, perforiranem za enkratne odmerke.
Following administration of 14C-rivastigmine, renal elimination was rapid and essentially complete (>90 %) within 24 hours. 
V 24 urah po uporabi 14C-rivastigmina je bilo izločanje skozi ledvice hitro in skoraj popolno
Protein binding of rivastigmine is approximately 40 %. 
Približno 40 % rivastigmina se veže na beljakovine plazme.
The active substance is rivastigmine 
Zdravilna učinkovina je rivastigmin.
Dose titration: Adverse reactions (e.g. hypertension and hallucinations in patients with Alzheimer's dementia and worsening of extrapyramidal symptoms, in particular tremor, in patients with dementia associated with Parkinson's disease) have been observed shortly after dose increase. 
Titracija odmerkov: Kmalu po povečanju odmerka so opazili neželene učinke (npr. hipertenzijo in halucinacije pri bolnikih z Alzheimerjevo demenco ter poslabšanje ekstrapiramidnih simptomov, zlasti tremorja, pri bolnikih z demenco, povezano s Parkinsonovo boleznijo).
Adjusted treatment difference p-value versus placebo 
Prilagojena razlika v zdravljenju vrednost p v primerjavi s placebom
You may have side effects more often when you start your medicine or when your dose is increased. 
Neželeni učinki bodo morda pogostejši ob začetku zdravljenja in ob zviševanju odmerka.
Frequency categories are defined using the following convention: very common (≥1/10); common (≥1/100 to <1/10); uncommon (≥1/1,000 to <1/100); rare (≥1/10,000 to <1/1,000); very rare (<1/10,000); not known (cannot be estimated from the available data). 
Pogostnost je definirana s pomočjo naslednjega dogovora: zelo pogosti (> 1/10); pogosti (> 1/100 do < 1/10); občasni (> 1/1000 do < 1/100); redki (> 1/10.000 do < 1/1000); zelo redki (< 1/10.000), neznana (ni mogoče oceniti iz razpoložljivih podatkov).
- 28, 56 or 112 capsules in transparent PVC/Alu push through blisters 
- 28, 50, 56 ali 112 kapsul v prosojnem pretisnem omotu iz PVC/Alu.
Taking this medicine 
Kako jemati to zdravilo
Capsule contents - microcrystalline cellulose, hypromellose, colloidal silicon dioxide, magnesium stearate. 
Pomožne snovi so: vsebina kapsule - mikrokristalna celuloza, hipromeloza, koloidni silicijev dioksid, magnezijev stearat.
The PSUR submission schedule for Rivastigmine TEVA hard capsules should follow PSURs submission schedule for the reference medicinal product. 
Načrt oddajanja PSUR-ov mora biti usklajen z načrtom oddajanja PSUR-ov za referenčno zdravilo.
Bottles 250 hard capsules 
Steklenice 250 trdih kapsul
Cholinomimetics may induce or exacerbate urinary obstruction and seizures. 
Holinomimetiki lahko sprožijo ali poslabšajo obstrukcijo sečil in epileptične napade.
As rivastigmine has a plasma half-life of about 1 hour and a duration of acetylcholinesterase inhibition of about 9 hours, it is recommended that in cases of asymptomatic overdose no further dose of rivastigmine should be administered for the next 24 hours. 
9 ur, zato je pri asimptomatičnem prevelikem odmerjanju priporočljivo naslednjih 24 ur prekiniti dajanje dodatnih odmerkov rivastigmina.
Metabolism and nutrition disorders Very common 
Presnovne in prehranske motnje Zelo pogosti
If you have to undergo surgery whilst taking Rivastigmine Teva, tell your doctor before you are given any anaesthetics, because Rivastigmine Teva may exaggerate the effects of some muscle relaxants during anaesthesia. 
preden vam dajo kakršenkoli anestetik, ker lahko zdravilo Rivastigmine Teva okrepi učinke nekaterih mišičnih relaksantov med anestezijo.
Pallagi út 13 
Swensweg 5
Mean change at 24 weeks ± SD 
Povprečna sprememba po 24
Sick sinus syndrome 
Bolezen sinusnega vozla
The following adverse reactions, listed below in Table 1, have been accumulated in patients with Alzheimer's dementia treated with rivastigmine. 
V tabeli 1 spodaj so prikazani neželeni učinki, ki so jih zbrali pri bolnikih z Alzheimerjevo demenco, ki so jemali rivastigmin.
Initial dose: 1.5 mg twice a day. 
Začetni odmerek: 1,5 mg dvakrat na dan.
NAME OF THE MARKETING AUTHORISATION HOLDER Teva Pharma B.V. 
IME IMETNIKA DOVOLJENJA ZA PROMET Z ZDRAVILOM Teva Pharma B.V.
Cholinesterase inhibitors, including rivastigmine, have been associated with weight loss in these patients. 
Z izgubo telesne mase pri teh bolnikih so povezani zaviralci holinesteraze, vključno z rivastigminom.
No dose adjustment is necessary for patientS with mild to moderate renal or hepatic impairment. 
Pri bolnikih z blago do zmerno okvaro ledvic ali jeter ni potrebno prilagajati odmerjanja.
Alzheimer's disease may cause gradual impairment of driving performance or compromise the ability to use machinery. 
4.7 Vpliv na sposobnost vožnje in upravljanja s stroji Alzheimerjeva bolezen lahko postopno zmanjša sposobnost vožnje ali poslabša zmožnost upravljanja s stroji.
Some cases of severe vomiting were associated with oesophageal rupture (see section 4.8). 
Nekateri primeri hudega bruhanja so bili povezani z rupturo ezofagusa (glejte poglavje 4.8).
- if you have, or have ever had, asthma or severe respiratory disease. 
- če imate ali ste kadarkoli imeli težave z uriniranjem, - če imate ali ste kadarkoli imeli epileptične napade, - če imate ali ste kadarkoli imeli astmo ali hudo bolezen dihal,
Iron oxide black 
črni železov oksid amonijev hidroksid
You may become dehydrated (losing too much fluid) if vomiting or diarhoea are prolonged. 
Če bruhanje ali driska trajata dolgo, lahko postanete dehidrirani (izgubite preveč tekočine).
Worsening (including bradykinesia, dyskinesia, gait abnormality) and an increased incidence or severity of tremor have been observed in patients with dementia associated with Parkinson's disease (see section 4.8). 
Pri bolnikih z demenco, povezano s Parkinsonovo boleznijo, so opazili poslabšanje (vključno z bradikinezijo, diskinezijo in motnjami hoje) in povečano pogostnost ali stopnjo tremorja (glejte poglavje 4.8).
Ink used for imprinting - Black S-1-17822/S-1-17823 Shellac glaze-45% 
Ovoj kapsule: titanov dioksid (E 171) želatina črnilo za tisk - črno S-1-17822/S-1-17823: glazura iz šelaka - 45 %
- if you have, or have ever had, an active stomach ulcer. 
- če imate ali ste kadarkoli imeli aktivno razjedo na želodcu,
Capsule contents Microcrystalline cellulose Hypromellose Colloidal silicon dioxide Magnesium stearate 
mikrokristalna celuloza hipromeloza koloidni silicijev dioksid magnezijev stearat
As a cholinesterase inhibitor, rivastigmine may exaggerate the effects of succinylcholine-type muscle relaxants during anaesthesia. 
Kot zaviralec holinesteraze lahko rivastigmin poslabša učinke sukcinilholinskih mišičnih relaksantov med anestezijo.
Some cases of severe vomiting were associated with oesophageal rupture (see section 4.4). 
Nekateri primeri hudega bruhanja so bili povezani z rupturo ezofagusa (glejte poglavje 4,4).
Swallow the capsules whole with a drink. 
• Kapsule pogoltnite cele z nekaj tekočine.
Dose titration: 
Titracija odmerkov:
Cholinesterase inhibitors should be prescribed with care to patients with a history of asthma or obstructive pulmonary disease. 
Bolnikom z astmo ali obstrukcijsko pljučno boleznijo v anamnezi je treba zaviralce holinesteraze predpisovati previdno.
Movement disorder Bradykinesia 
Diskinezija Parkinsonizem Hipokinezija Motnje gibanja Bradikinezija Distonija Motnje pri hoji
Rivastigmine Teva 1.5 mg hard capsules contains 1.5 mg rivastigmine as rivastigmine hydrogen tartrate 
Zdravilo Rivastigmine Teva 1.5 mg trde kapsule vsebuje 1,5 mg rivastigmina v obliki rivastigminhidrogentartrata.
They also have some additional side effects: 
Pri teh bolnikih so nekateri neželeni učinki bolj pogosti, poleg tega pa se pri njih pojavljajo nekateri dodatni neželeni učinki:
- If you have gastrointestinal reactions such as feeling sick (nausea) and being sick (vomiting) and diarrhoea. 
- če imate prebavne težave, kot so slabost s siljenjem na bruhanje (navzea), bruhanje in driska.
Fatigue and asthenia 
Utrujenost in astenija
Abdominal pain and dyspesia 
Bolečine v trebuhu in dispepsija
- HDPE tablet container with a polypropylene cap and induction seal: 250 capsules 
- Plastenka iz HDPE s polipropilenskim pokrovčkom in indukcijsko zatesnjenim vsebnikom:
• Feeling agitated 
• občutek nemira
- Rivastigmine Teva 1.5 mg hard capsules: White cap imprinted with “R” & white body 
- Rivastigmine Teva 1,5 mg trde kapsule: bela kapa z natisnjenim napisom »R« in belo telo z natisnjenim napisom »1.5«.
Hard capsule Orange colour cap imprinted with “R” & orange color body imprinted with “4.5” 
Trda kapsula Kapa oranžne barve z natisnjenim napisom »R« in telo oranžne barve z natisnjenim napisom »4,5«.
Not applicable. 
ni na voljo ni na voljo
Rivastigmine Teva 6 mg hard capsules contains 6 mg rivastigmine as rivastigmine hydrogen tartrate 
Zdravilo Rivastigmine Teva 6 mg trde kapsule vsebuje 6 mg rivastigmina v obliki rivastigminhidrogentartrata.
The highest dose that should be taken is 6.0 mg twice a day. 
• Najvišji dovoljeni odmerek je 6,0 mg dvakrat na dan.
SPECIAL WARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT 
POSEBNO OPOZORILO O SHRANJEVANJU ZDRAVILA ZUNAJ DOSEGA IN POGLEDA
If adverse reactions (e.g. nausea, vomiting, abdominal pain or loss of appetite), weight decrease or worsening of extrapyramidal symptoms (e.g. tremor) in patients with dementia associated with Parkinson's disease are observed during treatment, these may respond to omitting one or more doses. 
Če se pri bolnikih z demenco, povezano s Parkinsonovo boleznijo med zdravljenjem pojavijo neželeni učinki (npr. navzea, bruhanje, bolečine v trebuhu ali izguba apetita), če se zmanjša telesna masa ali če se poslabšajo ekstrapiramidni simptomi, (npr. tremor), bo morda treba izpustiti en ali več odmerkov.
If the dose is well tolerated after a minimum of two weeks of treatment, the dose may be increased to 3 mg twice a day. 
Če po najmanj dveh tednih zdravljenja bolniki odmerek dobro prenašajo, se lahko poveča na 3 mg dvakrat na dan. Tudi nadaljnje povečanje odmerka na 4,5 mg in nato na
The use of this medicinal product is contraindicated in patients with - hypersensitivity to the active substance, other carbamate derivatives or to any of the excipients 
- s preobčutljivostjo za zdravilno učinkovino, druge derivate karbamata ali katero koli pomožno snov
Always take Rivastigmine Teva exactly as your doctor has told you. 
Pri jemanju zdravila Rivastigmine Teva vedno upoštevajte zdravnikova navodila.
No pharmacokinetic interaction was observed between rivastigmine and digoxin, warfarin, diazepam or fluoxetine in studies in healthy volunteers. 
varfarinom, diazepamom ali fluoksetinom niso opazili.
Capsule contents Microcrystalline cellulose Hypromellose Colloidal silicon dioxide 
Vsebina kapsule: mikrokristalna celuloza hipromeloza koloidni silicijev dioksid magnezijev stearat
- If you are allergic (hypersensitive) to rivastigmine (the active substance in Rivastigmine Teva) 
- če ste alergični (preobčutljivi) na rivastigmin (zdravilno učinkovino v zdravilu Rivastigmine Teva) ali katero koli sestavino zdravila Rivastigmin Teva, ki je navedena v poglavju 6 tega navodila za
Fall 
Padci
Uncommon • Uneven heartbeat and poor control of movements 
Občasni • nepravilen srčni utrip in motnje koordinacije gibov
White cap imprinted with “R” & white body imprinted with “1.5” 
Trda kapsula Bela kapa z natisnjenim napisom »R« in belo telo z natisnjenim napisom »1.5«.
• Fainting or accidentally falling 
• omedlevica ali nezgodni padci • spremembe v delovanju jeter
Renal and hepatic impairment: 
Ledvična in jetrna okvara:
The mean actual daily dose for responders in the 6-12 mg group, corresponding to this definition, was 9.3 mg. 
Povprečni dejanski dnevni odmerek med bolniki, ki so se po tej opredelitvi odzvali na zdravljenje, v skupini, ki je prejemala 6-12 mg, je bil 9,3 mg. Pomembno je vedeti, da se lestvice, ki se uporabljajo pri tej indikaciji, razlikujejo, in da neposredno primerjanje rezultatov pri različnih terapevtskih učinkovinah ni primerno.
- if you have, or have ever had, impaired liver function. 
- če imate ali ste kadarkoli imeli okvarjeno delovanje ledvic,
HOW TO STORE RIVASTIGMINE TEVA 
Kaj vsebuje zdravilo Rivastigmine Teva
The Cmax of rivastigmine was approximately 60 % higher and the AUC of rivastigmine was more than twice as high in subjects with mild to moderate hepatic impairment than in healthy subjects. 
vrednost AUC rivastigmina pa več kot dvakrat večja, kot pri zdravih osebah.
PSURs 
PSURi
Subsequent increases to 4.5 mg and then 6 mg twice a day should also be based on good tolerability of the current dose and may be considered after a minimum of two weeks of treatment at that dose level. 
6 mg dvakrat na dan mora temeljiti na prenašanju trenutnega odmerka, poveča pa se lahko po najmanj dveh tednih zdravljenja s prejšnjim odmerkom.
Ink used for imprinting - Black S-1-17822/S-1-17823 
rumeni železov oksid (E 172) titanov dioksid (E 171) želatina črnilo za tisk - črno S-1-17822/S-1-17823
Therefore, the ability of patients with dementia on rivastigmine to continue driving or operating complex machines should be routinely evaluated by the treating physician. 
Lečeči zdravnik mora zato rutinsko ocenjevati sposobnost bolnikov z demenco, ki jemljejo rivastigmin za vožnjo in upravljanje s stroji.
Your doctor will tell you whether your illness allows you to drive vehicles and use machines safely.. Rivastigmine Teva may cause dizziness and somnolence, mainly at the start of treatment or when increasing the dose.If you feel dizzy or sleepy do not drive, use machines or perform any tasks that require your attention. 
Zdravnik vam bo povedal, ali vam vaša bolezen dovoljuje, da varno upravljate vozila in uporabljate stroje.
Skin and subcutaneous tissue disorders Common 
Bolezni kože in podkožja Pogosti
Elderly subjects: 
Starejše osebe:
- if you have, or have ever had, irregular heartbeat. 
- če imate ali ste kadarkoli imeli nereden srčni utrip,
or to any of the other ingredients of Rivastigmine Teva listed in section 6 of this leaflet - If this applies to you, tell your doctor and do not take Rivastigmine Teva. 
- Če kaj od navedenega velja za vas, povejte svojemu zdravniku in ne jemljite zdravila Rivastigmine
ITT + RDO population 
Populacija ITT + RDO (n = 329)
Cardiac disorders Common 
Občasni Srčne bolezni
General disorders and administration site conditions Common 
Splošne težave in spremembe na mestu aplikacije Pogosti
please tell your doctor or pharmacist. 
Če ste negotovi, se posvetujte z zdravnikom ali farmacevtom.
Mean baseline ± SD 
Malta Drugsales Ltd
Hard capsule Orange cap imprinted with “R” & flesh color body imprinted with “6” 
Trda kapsula Kapa oranžne barve z natisnjenim napisom »R« in telo svetlo rjave barve z natisnjenim napisom »6«.
Rash 
ŠS
Repeated-dose toxicity studies in rats, mice and dogs revealed only effects associated with an exaggerated pharmacological action. 
5.3 Predklinični podatki o varnosti Študije toksičnosti pri ponavljajočih se odmerkih pri podganah, miših in psih so pokazale samo učinke,
NAME OF THE MEDICINAL PRODUCT Rivastigmine Teva 1.5 mg hard capsules 
IME ZDRAVILA Rivastigmine Teva 1,5 mg trde kapsule
Rivastigmine Teva 1.5 mg hard capsules 
Rivastigmine Teva 1,5 mg trde kapsule rivastigmin
Vascular Disorders Very rare 
Infekcijske in parazitske bolezni Zelo redki
Rivastigmine Teva 4.5 mg hard capsules 
Rivastigmine Teva 4,5 mg trde kapsule rivastigmin
Table 2 shows the adverse reactions reported in patients with dementia associated with Parkison's disease treated with rivastigmine. 
V tabeli 2 so prikazani neželeni učinki, o katerih so poročali pri bolnikih z demenco, povezano s
• Severe confusion 
• hujšanje
Fits (seizures) 
• napadi krčev (epileptični napadi)
BATCH NUMBER BN 
ŠTEVILKA SERIJE ŠS
NAME OF THE MEDICINAL PRODUCT Rivastigmine Teva 4.5 mg hard capsules Rivastigmine 
IME ZDRAVILA Rivastigmine Teva 4,5 mg trde kapsule
B. CONDITIONS OF THE MARKETING AUTHORISATION 
POGOJI DOVOLJENJA ZA PROMET Z ZDRAVILOM
NAME OF THE MEDICINAL PRODUCT Rivastigmine Teva 6 mg hard capsules Rivastigmine 
IME ZDRAVILA Rivastigmine Teva 6 mg trde kapsule
NAME OF THE MEDICINAL PRODUCT Rivastigmine Teva 3 mg hard capsules Rivastigmine 
IME ZDRAVILA Rivastigmine Teva 3 mg trde kapsule
STATEMENT OF ACTIVE SUBSTANCE(S) Each capsule contains rivastigmine hydrogen tartrate corresponding to rivastigmine 4.5 mg 
Vsaka kapsula vsebuje rivastigminhidrogentartrat, kar ustreza 4,5 mg rivastigmina.
- Rivastigmine Teva 4.5 mg hard capsules: Orange colour cap imprinted with “R” & orange 
- Rivastigmine Teva 4,5 mg trde kapsule: kapa oranžne barve z natisnjenim napisom »R« in telo oranžne barve z natisnjenim napisom »4,5«.
PARTICULARS TO APPEAR ON THE IMMEDIATE PACKAGING Tablet container - Self-adhesive, paper label - Rivastigmine Teva 6 mg hard capsules 
Vsebnik s tabletami - samolepilna papirna oznaka - Rivastigmine Teva 6 mg trde kapsule
PARTICULARS TO APPEAR ON THE IMMEDIATE PACKAGING Tablet Container - Self-adhesive, paper label - Rivastigmine Teva 4.5 mg hard capsules 
Vsebnik s tabletami - samolepilna papirna oznaka - Rivastigmine Teva 4,5 mg trde kapsule
PARTICULARS TO APPEAR ON THE IMMEDIATE PACKAGING Tablet container - Self-adhesive, paper label - Rivastigmine Teva 1.5 mg hard capsules 
Vsebnik s tabletami - samolepilna papirna oznaka - Rivastigmine Teva 1,5 mg trde kapsule
BN 
V
Gastrointestinal disorders Very common Very common Very common Common 
Žilne bolezni Zelo redki Bolezni prebavil Zelo pogosti Zelo pogosti Zelo pogosti Pogosti
PARTICULARS TO APPEAR ON THE IMMEDIATE PACKAGING Tablet container - Self-adhesive, paper label - Rivastigmine Teva 3 mg hard capsules 
Vsebnik s tabletami - samolepilna papirna oznaka - Rivastigmine Teva 3 mg trde kapsule
Not known • Being violently sick (vomiting) that can cause tearing of the tube that connects your mouth with 
• močno bruhanje, ki lahko povzroči raztrganje požiralnika (cevi med usti in želodcem)
Weight loss 
Izguba telesne mase
STATEMENT OF ACTIVE SUBSTANCE(S) Each capsule contains rivastigmine hydrogen tartrate corresponding to rivastigmine 1.5 mg 
Vsaka kapsula vsebuje rivastigminhidrogentartrat, kar ustreza 1,5 mg rivastigmina.
PARTICULARS TO APPEAR ON THE OUTER PACKAGING Carton - Rivastigmine Teva 6 mg hard capsules 
PODATKI NA ZUNANJI OVOJNINI Škatla - Rivastigmine Teva 6 mg trde kapsule
PARTICULARS TO APPEAR ON THE OUTER PACKAGING Carton - Rivastigmine Teva 1.5 mg hard capsules 
PODATKI NA ZUNANJI OVOJNINI Škatla - Rivastigmine Teva 1,5 mg trde kapsule
PARTICULARS TO APPEAR ON THE OUTER PACKAGING Carton - Rivastigmine Teva 3 mg hard capsules 
PODATKI NA ZUNANJI OVOJNINI Škatla - Rivastigmine Teva 3 mg trde kapsule
- Rivastigmine Teva 6 mg hard capsules: Orange cap imprinted with “R” & flesh colour body 
- Rivastigmine Teva 6 mg trde kapsule: kapa oranžne barve z natisnjenim napisom »R« in telo svetlo rjave barve z natisnjenim napisom »6«.
WHAT RIVASTIGMINE TEVA IS AND WHAT IT IS USED FOR The active substance of Rivastigmine Teva is rivastigmine Rivastigmine belongs to a class of substances called cholinesterase inhibitors. 
Rivastigmin sodi v skupino učinkovin, ki jih imenujemo zaviralci holinesteraze.
Tell your doctor if you become pregnant during treatment. 
Če zanosite v času zdravljenja, obvestite svojega zdravnika.
STATEMENT OF ACTIVE SUBSTANCE(S) Each capsule contains rivastigmine hydrogen tartrate corresponding to rivastigmine 6 mg 
Vsaka kapsula vsebuje rivastigminhidrogentartrat, kar ustreza 6 mg rivastigmina.
PARTICULARS TO APPEAR ON THE OUTER PACKAGING Carton - Rivastigmine Teva 4.5 mg hard capsules 
PODATKI NA ZUNANJI OVOJNINI Škatla - Rivastigmine Teva 4,5 mg trde kapsule
STATEMENT OF ACTIVE SUBSTANCE(S) Each capsule contains rivastigmine hydrogen tartrate corresponding to rivastigmine 3 mg 
Vsaka kapsula vsebuje rivastigminhidrogentartrat, kar ustreza 3 mg rivastigmina.
To be swallowed whole without crushing or opening Read the package leaflet before use. 
Kapsule je treba pogoltniti cele, brez drobljenja ali odpiranja.
Pruritus 
Presnova
Rivastigmine 6-12 mg N=473 
Rivastigmin 6-12 mg
Magnesium stearate 
Prekomerno izločanje sline
Adjusted treatment difference n/a p-value versus placebo ITT - LOCF population (n=287) 
Populacija ITT + RDO (n = 87)